Alkermes Moves Beyond EDT Merger; Bullish On Pipeline
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly-reconfigured Alkermes reported third quarter fiscal 2013 earnings, highlighting how far it’s come since merging with the drug delivery unit of Elan a year ago and the strides it’s made with its pipeline of late.